Physician profile
Allison Lindquist
NPI 1568293553
$1,723.93
in general payments reported to CMS, 2019-2025
18 companies · $1,167 in 2025
The $1,167 reported for 2025 was more than what 89% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $557 · 2025: $1,167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,723.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $233.75 | 2024-2025 | |
| Incyte Corporation | $166.83 | 2024-2025 | Opzelura |
| Genzyme Corporation | $161.55 | 2024-2025 | |
| Pfizer INC. | $154.85 | 2024-2025 | |
| Lilly USA, LLC | $153.52 | 2024-2025 | Ebglyss, Taltz |
| Regeneron Healthcare Solutions, INC. | $105.16 | 2025 | Dupixent |
| Galderma Laboratories, L.P. | $97.25 | 2025 | Nemluvio |
| Novartis Pharmaceuticals Corporation | $94.63 | 2024-2025 | |
| Ucb, INC. | $93.72 | 2024-2025 | Bimzelx |
| Janssen Biotech, INC. | $93.53 | 2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $81.39 | 2025 | |
| Amgen INC. | $79.96 | 2024-2025 | Otezla, Otezla |
| E.R. Squibb & Sons, L.L.C. | $65.32 | 2024-2025 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $48.46 | 2025 | Zoryve |
| Paratek Pharmaceuticals, INC. | $38.38 | 2025 | Nuzyra |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biofrontera INC. | $24.93 | 2024 | Rhodoled Xl, Xepi, Bf-Rhodoled |
| Sandoz INC. | $20.82 | 2025 | Hyrimoz |
| Organon LLC | $9.88 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Lindquist listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.